The
development of outstanding noble-metal-free electrocatalysts
for the hydrogen evolution reaction (HER) has attracted broad interest.
Herein, a novel one-dimensional (1D) HER hybrid catalyst consisted
of cobalt phosphide (CoP) and molybdenum carbide (Mo2C)
nanoparticles wrapped by nitrogen-doped graphitic carbon (called CoP/Mo2C-NC) was successfully fabricated by a facile continuous-flow
method and a simple two-step annealing process. During these processes,
the successful synthesis of the MoO3 nanorods coated with
cobalt zeolitic imidazolate frameworks (Co-ZIF-67) (Co-ZIF-67@MoO3) through the continuous-flow method plays a key role. The
as-synthesized CoP/Mo2C-NC hybrid electrocatalyst exhibits
a significantly enhanced HER electrocatalytic activity over the entire
pH range relative to that of the control materials CoP, Mo2C-NC, and physically mixed CoP and Mo2C-NC. The outstanding
HER catalytic performance is mainly due to the fact that the electron
cloud transfers from Co to Mo in CoP/Mo2C-NC through the
Co–P–Mo bond, resulting in the formation of a high valence
state for Co (Co3+) species and lower valence states for
Mo (i.e., Mo2+, Mo3+) species, providing the
abundant HER active sites. Moreover, the Gibbs free energy (ΔG
H*) of CoP/Mo2C-NC obtained by the density function theory calculations
indicates a good balance between the Volmer and Heyrovsky/Tafel steps
in HER kinetics. Such a cobalt zeolitic imidazolate framework-mediated
strategy depicted in this work offers an interesting perspective for
developing highly efficient noble-metal-free electrocatalysts for
hydrogen production.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.